28 devices · GMDN 51050
Legionella pneumophila total antibody IVD kits use fluorescent immunoassay to detect antibodies against the bacteria responsible for Legionnaires’ disease. Clinically, these tests help confirm suspected infections by identifying immune responses to one or more serogroups of the pathogen in patient samples, aiding rapid diagnosis and treatment decisions.
These diagnostic tools are typically regulated as in vitro diagnostic medical devices, with classification and supply varying by jurisdiction. They are designed for laboratory use and require proper validation to ensure accuracy in detecting Legionella exposure, supporting clinical management of respiratory infections.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.